CVRx, Inc. (CVRX)

Latest Insider Confidence Score

2026Q1

49.7
Bearish

Company insider confidence (by quarter)

2021Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Johnson & Johnson 10% Owner 4,040,861 Dec 1, 2025
Johnson & Johnson Innovation - JJDC, Inc. 10% Owner 4,040,861 Dec 1, 2025
Nielsen Kirk G. Director 1,910,134 May 19, 2025
Pardo Geoffrey B Director 1,554,022 Jul 2, 2021
New Enterprise Associates 10 L P 10% Owner 1,196,911 Jul 7, 2021

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 2, 2026 Mar 4, 2026 Morrison Gregory CHIEF HUMAN RESOURCES OFFICER Neutral 90.0 +34,000 100.00% ✗ -
Mar 4, 2026 Morrison Gregory CHIEF HUMAN RESOURCES OFFICER Neutral 52.5 - 0.00% ✗ -
Feb 27, 2026 Mar 3, 2026 Hykes Kevin CEO Sell 95.0 +151,237 113.71% ✗ $61.3K
Feb 27, 2026 Mar 3, 2026 VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER Sell 91.3 +43,716 259.67% ✗ $10.1K
Feb 27, 2026 Mar 3, 2026 OASHEIM JARED CFO Sell 91.3 +59,256 158.24% ✗ $13.8K
Feb 27, 2026 Mar 3, 2026 John Robert Allen Chief Revenue Officer Sell 91.3 +31,036 56.43% ✗ $31.3K
Feb 27, 2026 Mar 3, 2026 Binkowski Brent COO Neutral 90.0 +15,000 90.36% ✗ -
Feb 20, 2026 Feb 23, 2026 Jain Mudit K. Director Buy 90.0 +46,800 4.98% ✗ $297.6K
Feb 18, 2026 Feb 18, 2026 Jain Mudit K. Director Buy 55.0 +600 0.06% ✗ $2.8K
Nov 25, 2025 Jan 8, 2026 JOHNSON & JOHNSON 10% Owner Sell 32.5 -22,337 -0.55% ✗ $224K
Nov 26, 2025 Dec 1, 2025 JOHNSON & JOHNSON 10% Owner Sell 47.5 -6,337 -0.16% ✗ $63.6K
Nov 21, 2025 Nov 25, 2025 JOHNSON & JOHNSON 10% Owner Sell 51.3 -2,700 -0.07% ✗ $27.1K
Nov 12, 2025 Nov 14, 2025 JOHNSON & JOHNSON 10% Owner Sell 51.3 -1,000 -0.02% ✗ $10K
Nov 6, 2025 Nov 10, 2025 JOHNSON & JOHNSON 10% Owner Sell 20.0 -52,532 -1.28% ✗ $536.3K
Aug 11, 2025 Aug 13, 2025 Binkowski Brent COO Neutral 90.0 +16,600 100.00% ✗ -
Aug 13, 2025 Binkowski Brent COO Neutral 52.5 - 0.00% ✗ -
Jun 3, 2025 Jun 5, 2025 Nielsen Kirk G. Director Neutral 52.5 - 0.00% ✗ -
Jun 3, 2025 Jun 5, 2025 Jain Mudit K. Director Neutral 52.5 - 0.00% ✗ -
Jun 3, 2025 Jun 5, 2025 SLATTERY JOSEPH P Director Neutral 52.5 - 0.00% ✗ -
Jun 3, 2025 Jun 5, 2025 Hill, Mitch C. Director Neutral 52.5 - 0.00% ✗ -
Jun 3, 2025 Jun 5, 2025 Ballinger Kevin J. Director Neutral 52.5 - 0.00% ✗ -
Jun 3, 2025 Jun 5, 2025 SHADAN MARTHA Director Neutral 52.5 - 0.00% ✗ -
May 15, 2025 May 19, 2025 Nielsen Kirk G. Director Buy 72.5 +10,966 0.58% ✗ $59.8K
May 12, 2025 May 14, 2025 Nielsen Kirk G. Director Buy 97.5 +187,813 10.97% ✗ $977.3K
May 12, 2025 May 13, 2025 Jain Mudit K. Director Buy 55.0 +1,650 0.18% ✗ $7.8K
May 12, 2025 May 12, 2025 Hykes Kevin CEO Buy 83.8 +5,000 3.91% ✗ $24.2K
Feb 28, 2025 Mar 4, 2025 Hykes Kevin CEO Neutral 90.0 +98,000 326.67% ✗ -
Feb 28, 2025 Mar 4, 2025 John Robert Allen Chief Revenue Officer Neutral 90.0 +55,000 100.00% ✗ -
Feb 28, 2025 Mar 4, 2025 OASHEIM JARED CFO Neutral 90.0 +22,000 142.42% ✗ -
Feb 28, 2025 Mar 4, 2025 Adamson Philip B. Chief Medical Officer Neutral 90.0 +20,000 100.00% ✗ -
Feb 28, 2025 Mar 4, 2025 VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER Neutral 90.0 +16,000 1916.17% ✗ -
Feb 14, 2025 Adamson Philip B. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Nov 19, 2024 Nov 21, 2024 VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER Sell 26.3 -2,470 -74.74% ✗ $19.4K
Sep 3, 2024 Sep 5, 2024 Ballinger Kevin J. Director Neutral 52.5 - 0.00% ✗ -
Sep 3, 2024 Sep 5, 2024 Hill, Mitch C. Director Neutral 52.5 - 0.00% ✗ -
Sep 5, 2024 Hill, Mitch C. Director Neutral 52.5 - 0.00% ✗ -
Sep 5, 2024 Ballinger Kevin J. Director Neutral 52.5 - 0.00% ✗ -
Aug 15, 2024 Aug 15, 2024 SLATTERY JOSEPH P Director Buy 91.3 +3,000 10.85% ✗ $24.3K
Aug 8, 2024 Aug 8, 2024 SLATTERY JOSEPH P Director Buy 91.3 +3,000 12.17% ✗ $24.7K
Aug 6, 2024 Aug 6, 2024 SLATTERY JOSEPH P Director Buy 91.3 +2,500 11.29% ✗ $22.7K
Aug 5, 2024 Aug 5, 2024 Hykes Kevin CEO Buy 97.5 +30,000 100.00% ✗ $250.8K
Jul 31, 2024 Aug 2, 2024 Hykes Kevin CEO Neutral 52.5 - 0.00% ✗ -
Jun 27, 2024 Jul 1, 2024 John Robert Allen Chief Revenue Officer Neutral 52.5 - 0.00% ✗ -
Jul 1, 2024 John Robert Allen Chief Revenue Officer Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 7, 2024 Behbahani Ali Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 7, 2024 Nielsen Kirk G. Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 7, 2024 SLATTERY JOSEPH P Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 7, 2024 Jain Mudit K. Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 7, 2024 SHADAN MARTHA Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 6, 2024 Behbahani Ali Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 6, 2024 SLATTERY JOSEPH P Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 6, 2024 Jain Mudit K. Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 6, 2024 SHADAN MARTHA Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 6, 2024 Nielsen Kirk G. Director Neutral 52.5 - 0.00% ✗ -
Mar 25, 2024 Mar 27, 2024 Palmer Craig E. SVP, U.S. SALES Neutral 52.5 - 0.00% ✗ -
Feb 23, 2024 Feb 27, 2024 VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER Neutral 27.5 -1,650 -67.21% ✗ -
Feb 20, 2024 Feb 22, 2024 VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER Sell 22.5 -2,545 -50.90% ✗ $55.7K
Feb 12, 2024 Feb 14, 2024 Hykes Kevin CEO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2024 Feb 6, 2024 Palmer Craig E. SVP, U.S. SALES Neutral 52.5 - 0.00% ✗ -
Feb 2, 2024 Feb 6, 2024 OASHEIM JARED CFO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2024 Feb 6, 2024 VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER Neutral 52.5 - 0.00% ✗ -
Feb 2, 2024 Feb 6, 2024 Yared Nadim CEO Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Feb 2, 2024 Johnson & Johnson Innovation - JJDC, Inc. 10% Owner Neutral 52.5 - 0.00% ✗ -
Feb 2, 2024 Johnson & Johnson Innovation - JJDC, Inc. 10% Owner Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 31, 2024 Yared Nadim CEO Neutral 52.5 - 0.00% ✗ -
Dec 28, 2023 Jan 2, 2024 SLATTERY JOSEPH P Director Neutral 52.5 - 0.00% ✗ -
Dec 14, 2023 Dec 18, 2023 Behbahani Ali Director Neutral 52.5 - 0.00% ✗ -
Oct 16, 2023 Oct 18, 2023 Galle Liz VP OF GLOBAL CLINICAL RESEARCH Neutral 52.5 - 0.00% ✗ -
Sep 18, 2023 Sep 20, 2023 OASHEIM JARED CFO Neutral 52.5 - 0.00% ✗ -
Sep 18, 2023 Johnson & Johnson Innovation - JJDC, Inc. 10% Owner Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Sep 18, 2023 Johnson & Johnson Innovation - JJDC, Inc. 10% Owner Neutral 27.5 -3,495,575 -100.00% ✗ -
Aug 3, 2023 Aug 7, 2023 VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER Sell 26.3 -628 -100.00% ✗ $11.7K
Jul 31, 2023 Aug 2, 2023 VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER Sell 26.3 -3,122 -83.25% ✗ $19.6K
Jun 5, 2023 Jun 7, 2023 Behbahani Ali Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2023 Jun 7, 2023 Jain Mudit K. Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2023 Jun 7, 2023 SLATTERY JOSEPH P Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2023 Jun 7, 2023 Hykes Kevin Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2023 Jun 7, 2023 SHADAN MARTHA Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2023 Jun 7, 2023 Nielsen Kirk G. Director Neutral 52.5 - 0.00% ✗ -
May 16, 2023 May 18, 2023 Palmer Craig E. SVP, U.S. SALES Neutral 52.5 - 0.00% ✗ -
Jan 18, 2023 Jan 20, 2023 Galle Liz VP OF GLOBAL CLINICAL RESEARCH Neutral 52.5 - 0.00% ✗ -
Jan 18, 2023 Jan 20, 2023 Palmer Craig E. SVP, U.S. SALES Neutral 52.5 - 0.00% ✗ -
Jan 18, 2023 Jan 20, 2023 OASHEIM JARED CFO Neutral 52.5 - 0.00% ✗ -
Jan 18, 2023 Jan 20, 2023 VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER Neutral 52.5 - 0.00% ✗ -
Jan 18, 2023 Jan 20, 2023 Yared Nadim CEO Neutral 52.5 - 0.00% ✗ -
Jan 11, 2023 Jan 13, 2023 Yared Nadim CEO Neutral 27.5 -7,080 -13.49% ✗ -
Dec 21, 2022 Dec 23, 2022 Hykes Kevin Director Neutral 52.5 - 0.00% ✗ -
Dec 23, 2022 Hykes Kevin Director Neutral 52.5 - 0.00% ✗ -
Nov 28, 2022 Nov 30, 2022 VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER Sell 22.5 -9,000 -100.00% ✗ $54.9K
Aug 2, 2022 Aug 4, 2022 VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER Neutral 52.5 - 0.00% ✗ -
Aug 2, 2022 Aug 4, 2022 Galle Liz VP OF GLOBAL CLINICAL RESEARCH Neutral 52.5 - 0.00% ✗ -
Aug 2, 2022 Aug 4, 2022 BRUHN-DING DEAN VP OF REG. AFFAIRS AND QA Neutral 52.5 - 0.00% ✗ -
Aug 2, 2022 Aug 4, 2022 Palmer Craig E. SVP, U.S. SALES Neutral 52.5 - 0.00% ✗ -
Aug 2, 2022 Aug 4, 2022 OASHEIM JARED CFO Neutral 52.5 - 0.00% ✗ -
Aug 2, 2022 Aug 4, 2022 Yared Nadim CEO Neutral 52.5 - 0.00% ✗ -
Jun 7, 2022 Jun 9, 2022 Behbahani Ali Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2022 Jun 9, 2022 Jain Mudit K. Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2022 Jun 9, 2022 SHADAN MARTHA Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2022 Jun 9, 2022 NEHRA JOHN M Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2022 Jun 9, 2022 Nielsen Kirk G. Director Neutral 52.5 - 0.00% ✗ -